Literature DB >> 24086946

Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis.

Pasquale Niscola1, Gianfranco Catalano, Stefano Fratoni, Laura Scaramucci, Paolo de Fabritiis, Tommaso Caravita.   

Abstract

Entities:  

Year:  2013        PMID： 24086946      PMCID： PMC3786286          DOI： 10.5045/br.2013.48.3.228

Source DB:  PubMed          Journal:  Blood Res        ISSN： 2287-979X


× No keyword cloud information.
  9 in total

1.  Development of a myeloproliferative disorder in a patient with monoclonal gammopathy of undetermined significance secreting immunoglobulin of the M class and treated with thalidomide and anti-CD20 monoclonal antibody.

Authors:  M C Kyrtsonis; S I Kokoris; F N Kontopidou; M P Siakantaris; C Kittas; G A Pangalis
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

2.  Rare coexistence of multiple myeloma with essential thrombocythemia: report of two cases.

Authors:  Navneet S Majhail; Alan E Lichtin
Journal:  Haematologica       Date:  2003-04       Impact factor: 9.941

3.  Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant.

Authors:  S G Holtan; J D Hoyer; F K Buadi
Journal:  Bone Marrow Transplant       Date:  2010-06-28       Impact factor: 5.483

4.  Essential thrombocythemia and multiple myeloma: two rare diseases in one patient.

Authors:  Ahmet Emre Eskazan; Seniz Ongoren; Muhlis Cem Ar; Teoman Soysal; Burhan Ferhanoglu; Hilal Aki; Yildiz Aydin
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-05-08

5.  Monoclonal gammopathy of undetermined significance in a case of primary thrombocythemia.

Authors:  F Tosato; V Fossaluzza; P Rossi; P Udina; S Mazzolini; P Sala; E Tonutti
Journal:  Haematologica       Date:  1986 Sep-Oct       Impact factor: 9.941

6.  Coexistent idiopathic thrombocythaemia and monoclonal component: a causal association?

Authors:  E Montefusco; B Monarca; M Tribalto
Journal:  Scand J Haematol       Date:  1985-11

Review 7.  How I treat POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

8.  JAK2V617F-positive essential thrombocythemia and multiple myeloma with IGH/CCND1 gene translocation coexist, but originate from separate clones.

Authors:  Junya Kuroda; Yosuke Matsumoto; Ruriko Tanaka; Kayoko Kurita; Tsutomu Kobayashi; Daisuke Shimizu; Shinya Kimura; Eishi Ashihara; Shigeo Horiike; Chihiro Shimazaki; Masafumi Taniwaki
Journal:  Acta Haematol       Date:  2009-01-05       Impact factor: 2.195

9.  Coexistence of essential thrombocythemia and multiple myeloma.

Authors:  F Prósper; J R Borbolla; J Rifón; B Cuesta; J Fernández; A Pinacho; E Rocha
Journal:  Ann Hematol       Date:  1992-08       Impact factor: 3.673
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.